Case report: multiple UGT1A1 gene variants in a patient with Crigler-Najjar syndrome

Abstract Background Inherited unconjugated hyperbilirubinemia is caused by variants in the gene UGT1A1 leading to Gilbert’s syndrome and Crigler-Najjar syndrome types I and II. These syndromes are differentiated on the basis of UGT1A1 residual enzymatic activity and its affected bilirubin levels and...

Full description

Bibliographic Details
Main Authors: Linda Gailite, Dmitrijs Rots, Ieva Pukite, Gunta Cernevska, Madara Kreile
Format: Article
Language:English
Published: BMC 2018-10-01
Series:BMC Pediatrics
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12887-018-1285-6
id doaj-fd47efeaec364158ab0b56e1e661ce60
record_format Article
spelling doaj-fd47efeaec364158ab0b56e1e661ce602020-11-24T20:42:49ZengBMCBMC Pediatrics1471-24312018-10-011811510.1186/s12887-018-1285-6Case report: multiple UGT1A1 gene variants in a patient with Crigler-Najjar syndromeLinda Gailite0Dmitrijs Rots1Ieva Pukite2Gunta Cernevska3Madara Kreile4Scientific Laboratory of Molecular Genetics, Riga Stradiņš UniversityScientific Laboratory of Molecular Genetics, Riga Stradiņš UniversityChildren’s Clinical University HospitalChildren’s Clinical University HospitalScientific Laboratory of Molecular Genetics, Riga Stradiņš UniversityAbstract Background Inherited unconjugated hyperbilirubinemia is caused by variants in the gene UGT1A1 leading to Gilbert’s syndrome and Crigler-Najjar syndrome types I and II. These syndromes are differentiated on the basis of UGT1A1 residual enzymatic activity and its affected bilirubin levels and responsiveness to phenobarbital treatment. Case presentation In this report, we present a boy with Crigler-Najjar syndrome type II with high unconjugated bilirubin levels that decreased after phenobarbital treatment but increased in adolescence. Four different UGT1A1 gene variants have been identified for this patient, of which one is novel (g.11895_11898del) most likely confirming diagnose molecularly. Conclusions The presented case highlights the challenges encountered with the interpretation of molecular data upon identification of multiple variants in one gene that are causing different degree reducing effect on enzyme activity leading to several clinical conditions.http://link.springer.com/article/10.1186/s12887-018-1285-6CNS-ICNS-IIUGT1A1
collection DOAJ
language English
format Article
sources DOAJ
author Linda Gailite
Dmitrijs Rots
Ieva Pukite
Gunta Cernevska
Madara Kreile
spellingShingle Linda Gailite
Dmitrijs Rots
Ieva Pukite
Gunta Cernevska
Madara Kreile
Case report: multiple UGT1A1 gene variants in a patient with Crigler-Najjar syndrome
BMC Pediatrics
CNS-I
CNS-II
UGT1A1
author_facet Linda Gailite
Dmitrijs Rots
Ieva Pukite
Gunta Cernevska
Madara Kreile
author_sort Linda Gailite
title Case report: multiple UGT1A1 gene variants in a patient with Crigler-Najjar syndrome
title_short Case report: multiple UGT1A1 gene variants in a patient with Crigler-Najjar syndrome
title_full Case report: multiple UGT1A1 gene variants in a patient with Crigler-Najjar syndrome
title_fullStr Case report: multiple UGT1A1 gene variants in a patient with Crigler-Najjar syndrome
title_full_unstemmed Case report: multiple UGT1A1 gene variants in a patient with Crigler-Najjar syndrome
title_sort case report: multiple ugt1a1 gene variants in a patient with crigler-najjar syndrome
publisher BMC
series BMC Pediatrics
issn 1471-2431
publishDate 2018-10-01
description Abstract Background Inherited unconjugated hyperbilirubinemia is caused by variants in the gene UGT1A1 leading to Gilbert’s syndrome and Crigler-Najjar syndrome types I and II. These syndromes are differentiated on the basis of UGT1A1 residual enzymatic activity and its affected bilirubin levels and responsiveness to phenobarbital treatment. Case presentation In this report, we present a boy with Crigler-Najjar syndrome type II with high unconjugated bilirubin levels that decreased after phenobarbital treatment but increased in adolescence. Four different UGT1A1 gene variants have been identified for this patient, of which one is novel (g.11895_11898del) most likely confirming diagnose molecularly. Conclusions The presented case highlights the challenges encountered with the interpretation of molecular data upon identification of multiple variants in one gene that are causing different degree reducing effect on enzyme activity leading to several clinical conditions.
topic CNS-I
CNS-II
UGT1A1
url http://link.springer.com/article/10.1186/s12887-018-1285-6
work_keys_str_mv AT lindagailite casereportmultipleugt1a1genevariantsinapatientwithcriglernajjarsyndrome
AT dmitrijsrots casereportmultipleugt1a1genevariantsinapatientwithcriglernajjarsyndrome
AT ievapukite casereportmultipleugt1a1genevariantsinapatientwithcriglernajjarsyndrome
AT guntacernevska casereportmultipleugt1a1genevariantsinapatientwithcriglernajjarsyndrome
AT madarakreile casereportmultipleugt1a1genevariantsinapatientwithcriglernajjarsyndrome
_version_ 1716821689792200704